TPMT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.515800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.421800E-01
Normal-vs-Stage2
4.579200E-01
Normal-vs-Stage3
4.892600E-01
Normal-vs-Stage4
2.172600E-01
Stage1-vs-Stage2
7.101400E-01
Stage1-vs-Stage3
9.306000E-01
Stage1-vs-Stage4
6.981200E-01
Stage2-vs-Stage3
8.515800E-01
Stage2-vs-Stage4
4.661600E-01
Stage3-vs-Stage4
7.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.925800E-01
Normal-vs-AfricanAmerican
2.972200E-01
Normal-vs-Asian
2.637000E-01
Caucasian-vs-AfricanAmerican
7.167400E-01
Caucasian-vs-Asian
2.214200E-01
AfricanAmerican-vs-Asian
6.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.067800E-01
Normal-vs-Female
3.753600E-01
Male-vs-Female
8.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.615200E-01
Normal-vs-Age(41-60Yrs)
3.544000E-01
Normal-vs-Age(61-80Yrs)
5.114200E-01
Normal-vs-Age(81-100Yrs)
4.477000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.524800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.944400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.612600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.926200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.701600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.762600E-01
Normal-vs-Daily Drinker
9.989800E-01
Normal-vs-Weekly Drinker
1.855800E-01
Normal-vs-Occasional Drinker
4.649400E-01
Normal-vs-Social Drinker
2.390400E-01
Non Drinker-vs-Daily Drinker
1.578230E-01
Non Drinker-vs-Weekly Drinker
4.558200E-01
Non Drinker-vs-Occasional Drinker
9.749400E-01
Non Drinker-vs-Social Drinker
4.981600E-01
Daily Drinker-vs-Weekly Drinker
1.851970E-02
Daily Drinker-vs-Occasional Drinker
1.460370E-01
Daily Drinker-vs-Social Drinker
2.569500E-02
Weekly Drinker-vs-Occasional Drinker
3.645600E-01
Weekly Drinker-vs-Social Drinker
9.307800E-01
Occasional Drinker-vs-Social Drinker
4.207400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.716800E-01
Normal-vs-Grade 2
3.837600E-01
Normal-vs-Grade 3
3.144400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.035420E-01
Grade 1-vs-Grade 3
3.916000E-01
Grade 1-vs-Grade 4
4.716800E-01
Grade 2-vs-Grade 3
3.646000E-01
Grade 2-vs-Grade 4
3.837600E-01
Grade 3-vs-Grade 4
3.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.379000E-01
Normal-vs-NonDiabetic
3.857000E-01
Diabetic-vs-NonDiabetic
9.631200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.898800E-01
Normal-vs-NoPancreatitis
4.961000E-01
Pancreatitis-vs-NoPancreatitis
9.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.982000E-01
Normal-vs-N1
4.684000E-01
N0-vs-N1
6.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.909960E-02
Normal-vs-TP53-NonMutant
1.434330E-02
TP53-Mutant-vs-TP53-NonMutant
7.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
